Daniel Cole is a versatile biotechnology corporate development professional currently serving as VP of Corporate Development at ERYTECH Pharma since 2021. They previously held roles at the same company as Strategic Marketing and Business Development Director from 2017 to 2022, as well as positions at Synta Pharmaceuticals, Spectrum Pharmaceuticals, Novacea, Ligand Pharmaceuticals, and Abraxis BioScience. They worked as an independent consultant from 2016 to 2022 and have extensive experience in corporate development and market analytics. Daniel is pursuing a Bachelor of Arts in Molecular Cell Biology (Immunology) at the University of California, Berkeley.
This person is not in the org chart
This person is not in any teams
This person is not in any offices